[Treatment and prevention of conjugation jaundice in newborn infants].
Risk factors of conjugation jaundice, developing in full-term newborns are listed. They should be taken into account at first neonatal examination of the infant in order to timely prevent marked hyperbilirubinemia. Treatment for conjugation jaundice should be combined and aim to improve hepatic activity and bilirubin lysis and withdrawal from the body.
Levitskaia
S K
SK
Elinevskaia
G F
GF
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D010789:Phototherapy; D012256:Riboflavin / Q000627:therapeutic use; D012996:Solutions
D000900:Anti-Bacterial Agents; D012996:Solutions; D005947:Glucose; D012256:Riboflavin
Lechenie i profilaktika konïugatsionnoĭ zheltukhi u novorozhdennykh.